Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 252-021-1 | CAS number: 34432-92-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 17. 9. – 2. 10.2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study was carried out in accordance with internationally valid GLP principles.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: breeding farm VELAZ s.r.o., Koleč u Kladna, Czech Republic
- Age at study initiation: 8-10 weeks
- Weight at study initiation: 152-160 g
- Fasting period before study: 20 h
- Housing: animal room with monitoring conditions – 3 animals of one sex in one plastic breeding cage Velaz T4
- Diet (e.g. ad libitum): ST 1 BERGMAN – standard pelleted diet ad libitum
- Water (e.g. ad libitum): drinking tap water ad libitum
- Acclimation period: min 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/- 3°C
- Relative humidity (%): 30-70%
- Air changes (per hr): approximately 15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12-hour light/12 hour dark
STUDY TIME SCHEDULE
Animal supply: 12. 09. 2012
Experimental part of study: 17. 09. - 02. 10. 2012 - Route of administration:
- oral: gavage
- Vehicle:
- olive oil
- Details on oral exposure:
- VEHICLE
- Lot/batch no. (if required): 5211201
- Purity:pharmaceutical quality
MAXIMUM DOSE VOLUME APPLIED: The single volume of administered suspension was 1ml/100 g of animal body weight.
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: (according to EU Method B.1tris, Annex 1D)
START: 2000 mg/kg – 3 females (Step No.1): 2 females died and one female was humanely killed ► 300 mg/kg – 3 females (Step No. 2): no death ► 300 mg/kg – 3 females (Step No. 3): no death ► END of study - Doses:
- 2000 mg/kg b.w.
- No. of animals per sex per dose:
- 3 females (step 1), 3 females (step 2), 3 females (step 3)
- Control animals:
- no
- Details on study design:
- Details on study design
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Body weight: before application, 8th day and before euthanasia of animals
Mortality: daily
Clinical examination:
the first day: twice (30 minutes and 3 hours after application)
the second day: twice (in the morning and in the afternoon) and daily thereafter for 14 days.
- Necropsy of survivors performed: yes - Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- >= 300 - <= 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- At the dose of 2000 mg/kg: 2 females died and one female was humanely killed by reason of moribund condition on the 3rd day morning
At the dose of 300 mg/kg: no death - Clinical signs:
- other: other: 2000 mg/kg: The clinical signs of intoxication (piloerection, gibbous posture) were detected 30 minutes after the 1st day of application in all three animals. The skin, fur and visible mucous membranes coloured by test substance, gibbous posture, l
- Gross pathology:
- 2000 mg/kg:
Changes observed in all animals: skin, fur and visible mucous membranes coloured by the test substance; red discharge from nostril; cachexy; subcutaneous and skeletal muscle coloured by the test substance; dilatation and haemorrhagic inflammation (erosion) of stomach; chymus and intestines coloured by the test substance, blood in chymus; spleen decreased and pale; urine dark coloured.
300 mg/kg: The pathologic macroscopic changes (fat coloured by the test substance) were diagnosed during pathological examination - Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- According to the study results the value of LD50 of the test substance, Solvent Yellow 124, for rats is in the range > 300 mg/kg to ≤ 2000 mg/kg.
- Executive summary:
The aim of the study was to investigate acute toxic effects of the test substance Solvent Yellow 124, after a single oral administration to Wistar rats.
The testing was performed according to the Method B.1 tris: Acute Oral Toxicity - Acute Toxic Class Method, Council Regulation (EC) No.440/2008, published in O.J. L 142, 2008.
The test substance was administered in a single dose as solution in vehicle (olive oil), given orally via gavage to two groups of three female Wistar rats. The dosing was performed sequentially in three groups of three females: group No. 1 (first step) using the starting dose of 2000 mg/kg body weight, group No. 2 (second step) and group No. 3 (third step) using a dose of 300 mg/kg body weight. The volume of administered solution was 1 ml/100 g body weight of animals.
The test substance administered at the dose of 2000 mg/kg caused death of two animals and one animal was humanely killed by reason of moribund condition on the 3rd day morning.
The clinical signs of intoxication (piloerection, gibbous posture) were detected 30 minutes after the 1st day of application in all three animals. The skin, fur and visible mucous membranes coloured by test substance, gibbous posture, lurch tiptoe up gait, abdomen up and head down position, decreased response to stimuli, red discharge from nostril, tachypnoea, diarrhoea (excrements and bedding coloured by the test substance) were detected 3 hours after application. The 2nd day of application in all three animals skin, fur and visible mucous membranes coloured by the test substance, gibbous posture, immobility, without reaction to stimuli, dyspnoea, diarrhoea (excrements and bedding coloured by the test substance) were diagnosed. During pathological examination the following changes were observed in all animals: skin, fur and visible mucous membranes coloured by the test substance; red discharge from nostril; cachexy; subcutaneous and skeletal muscle coloured by the test substance; dilatation and haemorrhagic inflammation (erosion) of stomach; chymus and intestines coloured by the test substance, blood in chymus; spleen decreased and pale; urine dark coloured.
The test substance administered at the dose of 300 mg/kg caused no death in any of two administered groups of females (group No.2 and No. 3).
Clinical signs of intoxication (skin, fur and visible mucous membranes coloured by the test substance) were observed from 2nd to 5th day of application in all six animals.
The pathologic macroscopic changes (fat coloured by the test substance) were diagnosed during pathological examination.
According to the study results the value of LD50 of the test substance, Solvent Yellow 124, for rats is in the range > 300 mg/kg to ≤ 2000 mg/kg.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 300 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Justification for classification or non-classification
According to the study results the value of LD50(oral) of the test substance, Solvent Yellow 124, for rats is in the range > 300 mg/kg to ≤ 2000 mg/kg and it relate to Category 4 classification.
According to the results of study, the value of LD50 (dermal) of the test substance, Solvent Yellow 124, for rats of both sexes is higher than 2000 mg/kg of body weight. Because of mild character of clinical and macroscopic effects it was concluded that they did not influence the classification of the test substance.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.